These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11301566)

  • 1. Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women.
    Tsunoda SM; Harris RZ; Mroczkowski PJ; Benet LZ
    J Clin Pharmacol; 1998 Dec; 38(12):1137-43. PubMed ID: 11301566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics.
    Harris RZ; Tsunoda SM; Mroczkowski P; Wong H; Benet LZ
    Clin Pharmacol Ther; 1996 Apr; 59(4):429-35. PubMed ID: 8612388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone.
    McCune JS; Hawke RL; LeCluyse EL; Gillenwater HH; Hamilton G; Ritchie J; Lindley C
    Clin Pharmacol Ther; 2000 Oct; 68(4):356-66. PubMed ID: 11061575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans.
    Mouly S; Lown KS; Kornhauser D; Joseph JL; Fiske WD; Benedek IH; Watkins PB
    Clin Pharmacol Ther; 2002 Jul; 72(1):1-9. PubMed ID: 12151999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
    Blode H; Zeun S; Parke S; Zimmermann T; Rohde B; Mellinger U; Kunz M
    Contraception; 2012 Oct; 86(4):337-44. PubMed ID: 22445438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the erythromycin breath test for use in cancer patients.
    Rivory LP; Slaviero K; Seale JP; Hoskins JM; Boyer M; Beale PJ; Millward MJ; Bishop JF; Clarke SJ
    Clin Cancer Res; 2000 Sep; 6(9):3480-5. PubMed ID: 10999732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin.
    Paine MF; Wagner DA; Hoffmaster KA; Watkins PB
    Clin Pharmacol Ther; 2002 Nov; 72(5):524-35. PubMed ID: 12426516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
    Mathijssen RH; de Jong FA; van Schaik RH; Lepper ER; Friberg LE; Rietveld T; de Bruijn P; Graveland WJ; Figg WD; Verweij J; Sparreboom A
    J Natl Cancer Inst; 2004 Nov; 96(21):1585-92. PubMed ID: 15523087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of cytochrome P4503A substrates in vivo administered by the same route: lack of correlation between alfentanil clearance and erythromycin breath test.
    Krivoruk Y; Kinirons MT; Wood AJ; Wood M
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):608-14. PubMed ID: 7995002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
    Lown KS; Kolars JC; Thummel KE; Barnett JL; Kunze KL; Wrighton SA; Watkins PB
    Drug Metab Dispos; 1994; 22(6):947-55. PubMed ID: 7895614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-dose vitamin C on hepatic cytochrome P450 3A4 activity.
    van Heeswijk RP; Cooper CL; Foster BC; Chauhan BM; Shirazi F; Seguin I; Phillips EJ; Mills E
    Pharmacotherapy; 2005 Dec; 25(12):1725-8. PubMed ID: 16305291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erythromycin breath test for the prediction of drug clearance.
    Rivory LP; Slaviero KA; Hoskins JM; Clarke SJ
    Clin Pharmacokinet; 2001; 40(3):151-8. PubMed ID: 11327195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Gorski JC; Wainer IW; Schwartz JB
    Clin Pharmacol Ther; 1999 Jul; 66(1):40-50. PubMed ID: 10430108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
    Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
    Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mibefradil on CYP3A4 in vivo.
    Veronese ML; Gillen LP; Dorval EP; Hauck WW; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Oct; 43(10):1091-100. PubMed ID: 14517191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 3A4 activity in premenopausal and postmenopausal women, based on 6-beta-hydroxycortisol:cortisol ratios.
    Burstein AH; Reiss WG; Kantor E; Anderson GD
    Pharmacotherapy; 1998; 18(6):1271-6. PubMed ID: 9855326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.